Tatsuro Mori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatsuro Mori has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Yoichi Katayama
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
3 shared publicationsTeruyasu Hirayama
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
2 shared publicationsAkihisa Katagiri
1 shared publicationJun Kojima
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
1 shared publication- Masamichi Fukushima
Division of Neurosurgery, Department of Neurological Surgery, Nihon University School of Medicine , Itabashi, Tokyo , Japan
1 shared publication - Nobuhiro Moro
Department of Neurological SurgeryNihon University School of Medicine, Tokyo, Japan
1 shared publication
Latest Publications
- 1 December 2012
- Published by Taylor & Francis in Neurological Research
- Vol. 34 (10) , 1016-1019
Is the circulating plasma volume sufficiently maintained? Fluid management of an aneurysmal subarachnoid hemorrhage in the acute phase
Cerebral vasospasm is a well-known cause of mortality and morbidity following aneurysmal subarachnoid hemorrhage (SAH). Prevention of symptomatic cerebral vasospasm is the basic management after SAH. Numerous pharmaceutical therapies and endovascular treatments are available against cerebral vasospasm, but none of them have so far proven to improve the outcome. We have focused on maintaining the circulation volume in order to prevent cerebral vasospasm. But to maintain the central venous pressure, huge infusion volume was required, and hyponatremia was frequently observed due to natriuresis and osmotic diuresis. Excessive natriuresis and diuresis cannot be managed through sodium and water replacement, since sodium replacement induces further natriuresis and diuresis (desalination), and water replacement induces hyponatremia. We therefore administered fludrocortisone and hydrocortisone to inhibit excessive natriuresis and diuresis. The efficacy of sodium reabsorption therapy is extremely high to maintain the circulation volume that might have a therapeutic effect to prevent cerebral vasospasm. In this article, we review our institution's experience regarding the management of patients with aneurysmal SAH and also discuss the importance of water and sodium balance when managing such patients.
- 1 December 2012
- Published by Taylor & Francis in Neurological Research
- Vol. 34 (10) , 1016-1019
Is the circulating plasma volume sufficiently maintained? Fluid management of an aneurysmal subarachnoid hemorrhage in the acute phase
Cerebral vasospasm is a well-known cause of mortality and morbidity following aneurysmal subarachnoid hemorrhage (SAH). Prevention of symptomatic cerebral vasospasm is the basic management after SAH. Numerous pharmaceutical therapies and endovascular treatments are available against cerebral vasospasm, but none of them have so far proven to improve the outcome. We have focused on maintaining the circulation volume in order to prevent cerebral vasospasm. But to maintain the central venous pressure, huge infusion volume was required, and hyponatremia was frequently observed due to natriuresis and osmotic diuresis. Excessive natriuresis and diuresis cannot be managed through sodium and water replacement, since sodium replacement induces further natriuresis and diuresis (desalination), and water replacement induces hyponatremia. We therefore administered fludrocortisone and hydrocortisone to inhibit excessive natriuresis and diuresis. The efficacy of sodium reabsorption therapy is extremely high to maintain the circulation volume that might have a therapeutic effect to prevent cerebral vasospasm. In this article, we review our institution's experience regarding the management of patients with aneurysmal SAH and also discuss the importance of water and sodium balance when managing such patients.
- 1 April 2010
- Vol. 38 (4) , 371-7
[Case of skull metastasis from hepatocellular carcinoma at the site of skull fracture].
It has occasionally been reported that mechanical trauma and posttraumatic inflammation may promote metastasis from a primary tumor to the site of the trauma. However, the etiologies that contribute to the metastasis formation at the trauma site remain unknown. We describe here the first case of skull metastasis from hepatocellular carcinoma (HCC) revealing a growing subcutaneous mass at the site of skull fracture. A 58-year-old man had undergone surgical resection of a primary tumor in the liver 2 years previously and was in clinical remission. The patient fell head first off his bicycle and suffered a skull fracture in the squamous portion of the left temporal bone without ostelysis. Three months after the head trauma, he presented at our department with a growing lump on the left side of his head, and magnetic resonance (MR) imaging revealed an osteolytic tumor extending into the adjacent subcutaneous and epidural space. The tumor was at the same location as the skull fracture sustained in the bicycle accident. The mass lesion was radically resected with surrounding normal bone. The tumor formed a well-demarcated mass with osteolysis of the inner and outer skull tables, and the inner layer of the dura mater was intact. The histological diagnosis for the surgical specimen from the skull tumor was a HCC identical to the primary tumor. Immunohistochemically, the tumor cells were diffusely and strongly positive for vascular endothelial growth factor (VEGF) and basic fibrous growth factor (bFGF). It is well known that the extracellular matrix and cytokines are involved in the processes of not only bone healing but also metastasis formation. The present case suggests that several processes involved in bone healing modified the microenvironment and represent a possible cause of skull metastasis from primary tumor.
- 1 April 2010
- Vol. 38 (4) , 371-7
[Case of skull metastasis from hepatocellular carcinoma at the site of skull fracture].
It has occasionally been reported that mechanical trauma and posttraumatic inflammation may promote metastasis from a primary tumor to the site of the trauma. However, the etiologies that contribute to the metastasis formation at the trauma site remain unknown. We describe here the first case of skull metastasis from hepatocellular carcinoma (HCC) revealing a growing subcutaneous mass at the site of skull fracture. A 58-year-old man had undergone surgical resection of a primary tumor in the liver 2 years previously and was in clinical remission. The patient fell head first off his bicycle and suffered a skull fracture in the squamous portion of the left temporal bone without ostelysis. Three months after the head trauma, he presented at our department with a growing lump on the left side of his head, and magnetic resonance (MR) imaging revealed an osteolytic tumor extending into the adjacent subcutaneous and epidural space. The tumor was at the same location as the skull fracture sustained in the bicycle accident. The mass lesion was radically resected with surrounding normal bone. The tumor formed a well-demarcated mass with osteolysis of the inner and outer skull tables, and the inner layer of the dura mater was intact. The histological diagnosis for the surgical specimen from the skull tumor was a HCC identical to the primary tumor. Immunohistochemically, the tumor cells were diffusely and strongly positive for vascular endothelial growth factor (VEGF) and basic fibrous growth factor (bFGF). It is well known that the extracellular matrix and cytokines are involved in the processes of not only bone healing but also metastasis formation. The present case suggests that several processes involved in bone healing modified the microenvironment and represent a possible cause of skull metastasis from primary tumor.
- 1 January 1998
- Published by Japanese Society on Surgery for Cerebral Stroke in Surgery for Cerebral Stroke
- Vol. 26 (4) , 265-269
Management of Sodium Balance by Using Fludrocortisone Acetate in Patients with Subarachnoid Hemorrhage in the Acute Stage
On the basis of the concept of central salt wasting syndrome, hypotonic dehydration due to sodium-diuresis is considered to be a cause of cerebral vasospasms. To treat hyponatremia found in the acute stage of ruptured cerebral aneurysm, when sodium is solely supplemented, a large volume of infusion is required because of acceleration of sodium excretion. This makes treatment difficult in many cases. Hence, paying attention to the sodium balance in the acute stage of subarachnoid hemorrhage, we examined the effect of fludrocortisone acetate, a mineralocorticoid which accelerates resorption of sodium in the renal tubules on the sodium balance.The subjects were 25 patients with ruptured cerebral aneurysm who underwent radical operation within 2 days after onset. They were allocated into fludrocortisone acetate (0.3mg/day) administration group (N=10) and no administration group (N=15) and at random. During the course of administration, infusion was performed actively using water balance and CVP as indexes. Sodium in serum and urine was continuously monitored, and a sodium balance sheet was made.In the no administration group, the sodium balance tended to be negative from the third day after onset, accompanied by urine volume increase. In the fludrocortisone acetate administration group, decreased sodium excretion in urine was observed and the water balance was easily corrected. In addition, the prevalence of symptomatic cerebral vasospasms tended to be low.In the acute stage of subarachnoid hemorrhage, the water and sodium balances tend to be negative from the third day after onset, and patients become dehydrated. When this state lasts a long time without correction, hyponatremia and symptomatic cerebral vasospasms occur easily. To avoid this state, administration of fludrocortisone acetate appeared to be effective.
- 1 January 1998
- Published by Japanese Society on Surgery for Cerebral Stroke in Surgery for Cerebral Stroke
- Vol. 26 (4) , 265-269
Management of Sodium Balance by Using Fludrocortisone Acetate in Patients with Subarachnoid Hemorrhage in the Acute Stage
On the basis of the concept of central salt wasting syndrome, hypotonic dehydration due to sodium-diuresis is considered to be a cause of cerebral vasospasms. To treat hyponatremia found in the acute stage of ruptured cerebral aneurysm, when sodium is solely supplemented, a large volume of infusion is required because of acceleration of sodium excretion. This makes treatment difficult in many cases. Hence, paying attention to the sodium balance in the acute stage of subarachnoid hemorrhage, we examined the effect of fludrocortisone acetate, a mineralocorticoid which accelerates resorption of sodium in the renal tubules on the sodium balance.The subjects were 25 patients with ruptured cerebral aneurysm who underwent radical operation within 2 days after onset. They were allocated into fludrocortisone acetate (0.3mg/day) administration group (N=10) and no administration group (N=15) and at random. During the course of administration, infusion was performed actively using water balance and CVP as indexes. Sodium in serum and urine was continuously monitored, and a sodium balance sheet was made.In the no administration group, the sodium balance tended to be negative from the third day after onset, accompanied by urine volume increase. In the fludrocortisone acetate administration group, decreased sodium excretion in urine was observed and the water balance was easily corrected. In addition, the prevalence of symptomatic cerebral vasospasms tended to be low.In the acute stage of subarachnoid hemorrhage, the water and sodium balances tend to be negative from the third day after onset, and patients become dehydrated. When this state lasts a long time without correction, hyponatremia and symptomatic cerebral vasospasms occur easily. To avoid this state, administration of fludrocortisone acetate appeared to be effective.